Evidence map›Paper›PMID 36416374›Full record

ArticleHistopathology2023

Myelofibrosis progression grading based on type I and type III collagen and fibrillin 1 expression boosted by whole slide image analysis.

Tamas Szekely, Barna Wichmann, Mate E Maros, Annamaria Csizmadia, Csaba Bodor, Botond Timar, Tibor Krenacs

Open access · hybridAbstract read
In one paragraph

Article in Histopathology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
0.8field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 5 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Tamas SzekelyDepartment of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
Barna WichmannDepartment of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
Mate E MarosDepartment of Biomedical Informatics at the Center for Preventive Medicine and Digital Health, Medical Faculty Mannheim, Heidelberg University, Mannheim, Germany.
Annamaria CsizmadiaDepartment of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
Csaba BodorDepartment of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
Botond TimarDepartment of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.ORCID https://orcid.org/0000-0001-6210-8154
Tibor KrenacsDepartment of Pathology and Experimental Cancer Research, Semmelweis University, Budapest, Hungary.
Semmelweis University · HUUniversity of Mannheim · DE

Funding

EU's Horizon 2020 Research and Innovation Program 739593
6 · The paper itself

Abstract

aimsThe progression of primary myelofibrosis is characterised by ongoing extracellular matrix deposition graded based on 'reticulin' and 'collagen' fibrosis, as revealed by Gomori's silver impregnation. Here we studied the expression of the major extracellular matrix proteins of fibrosis in relation to diagnostic silver grading supported by image analysis. METHODS AND

resultsBy using automated immunohistochemistry, in this study we demonstrate that the expression of both types I and III collagens and fibrillin 1 by bone marrow stromal cells can reveal the extracellular matrix scaffolding in line with myelofibrosis progression as classified by silver grading. 'Reticulin' fibrosis indicated by type III collagen expression and 'collagen' fibrosis featured by type I collagen expression were parallel, rather than sequential, events. This is line with the proposed role of type III collagen in regulating type I collagen fibrillogenesis. The uniformly strong fibrillin 1 immune signals offered the best inter-rater agreements and the highest statistical correlations with silver grading of the three markers, which was robustly confirmed by automated whole slide digital image analysis using a machine learning-based algorithm. The progressive up-regulation of fibrillin 1 during myelofibrosis may result from a negative feedback loop as fibrillin microfibrils sequester TGF-β, the major promoter of fibrosis. This can also reduce TGF-β-induced RANKL levels, which would stimulate osteoclastogenesis and thus can support osteosclerosis in advanced myelofibrosis.

conclusionsThrough the in-situ detection of these extracellular matrix proteins, our results verify the molecular pathobiology of fibrosis during myelofibrosis progression. In particular, fibrillin 1 immunohistochemistry, with or without image analysis, can complement diagnostic silver grading at decent cell morphology.

Indexed as

Primary MyelofibrosisCollagenCollagen Type ICollagen Type IIIExtracellular Matrix ProteinsFibrillin-1FibrosisHumansSilverTransforming Growth Factor betaCollagenCollagen Type ICollagen Type IIIExtracellular Matrix ProteinsFibrillin-1SilverTransforming Growth Factor betafibrillin 1primary myelofibrosis progressiontype I collagentype III collagenwhole slide digital image analysis

Identifiers

PMID36416374
PMCPMC10107930
OpenAlexW4309789940

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.